Construction and expression of attenuated salmonella typhimurium carrying human adiponectin gene eukaryotic expression vector
ZHOU Jing,ZHOU Zhou,WU Ying,XIANG Ting-Xiu,JIANG Zheng,WANG Pi-Long
2009-01-01
Abstract:AIM:To construct and express an attenuated Salmonella typhimurium strain contraining human adiponectin gene eukaryoticexpression vector,in order to lay the foundation for the genetic therapy of nonalcoholic fatty liver disease in future.METHODS:Total mRNA was extracted from human fat tissue and the adiponectin cDNA was obtained by RT-PCR,and then cloned into eukaryotic expression vector pEGFP-N1.The recombinant vector was identified,and transformed into attenuated Salmonella typhimurium strain SL7207,and the recombinant strain SL7207/pEGFP-N1-AdipoQ was screened by green fluorescent microscopeand Western Blot.RESULTS:Enzyme digestion analysis and sequencing showed that the target genes was found to be 744 bp,and had been inserted into eukaryotic expression vector,but as compared with gene reported by GenBank,0.1% of the gene mutation and 0.4% of amino acid residues change,respectively:654 bp:A→T,amino acids:Glu→Asp.SDS-PAGE demonstrated that pEGFP-N1-AdipoQ was expressed in SL7207 strain,and the relatived molecular mass of the GFP-AdipoQ fusion protein was about 55×103,while GFP protein expressed by pEGFP-N1 was about 27×103.The Western Blot analysis indicated that the EGFP-AdipoQ fusion protein could be recognized by anti-AdipoQ antibody,suggesting that this fusion protein had good biological activity.CONCLUSION:The recombinant attenuated Salmonella typhimurium strain contraining plasmid pEGFP-N1-AdipoQ can be successfully constructed and expressed,and can be a basic foundation for the genetic therapy of NFLD in future with adiponectin.